Search research articles
Contact Us
Filters
Showing results (141-150 of 216) with videos related to
Page
of 22
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
March 1, 2014
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC
Michael Michael, Shane C White, Ehtesham Abdi, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 8, 2020
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (<sup>18</sup> F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors
Mei Sim Lung, Rodney J Hicks, Nick Pavlakis, et al.
Targeted Oncology
|
June 8, 2017
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
Michael Michael, Yung-Jue Bang, Young Suk Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
Ian D Davis, Lynette Kiers, Lachlan MacGregor, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 22, 2018
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2019
The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma
Grace Kong, Tess Schenberg, Christopher J Yates, et al.
Diseases of the Colon and Rectum
|
March 20, 2021
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis
Michael P Flood, Atandrila A Das, Mikael L Soucisse, et al.
Contemporary Clinical Trials Communications
|
October 26, 2019
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)
Toan Pham, Lloyd Pereira, Sara Roth, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 25, 2014
Impact of advancing age on treatment and outcomes in anal cancer
Marcus Foo, Emma Link, Trevor Leong, et al.
ANZ Journal of Surgery
|
May 9, 2022
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases in an elderly population: outcomes from a single centre
Michael P Flood, Vignesh Narasimhan, Peadar S Waters, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 216) with videos related to
Sort By:
Page
of 22
Asia-Pacific Journal of Clinical Oncology
|
March 1, 2014
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC
Michael Michael, Shane C White, Ehtesham Abdi, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 8, 2020
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (<sup>18</sup> F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors
Mei Sim Lung, Rodney J Hicks, Nick Pavlakis, et al.
Targeted Oncology
|
June 8, 2017
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
Michael Michael, Yung-Jue Bang, Young Suk Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
Ian D Davis, Lynette Kiers, Lachlan MacGregor, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 22, 2018
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2019
The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma
Grace Kong, Tess Schenberg, Christopher J Yates, et al.
Diseases of the Colon and Rectum
|
March 20, 2021
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis
Michael P Flood, Atandrila A Das, Mikael L Soucisse, et al.
Contemporary Clinical Trials Communications
|
October 26, 2019
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)
Toan Pham, Lloyd Pereira, Sara Roth, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 25, 2014
Impact of advancing age on treatment and outcomes in anal cancer
Marcus Foo, Emma Link, Trevor Leong, et al.
ANZ Journal of Surgery
|
May 9, 2022
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases in an elderly population: outcomes from a single centre
Michael P Flood, Vignesh Narasimhan, Peadar S Waters, et al.
Page
of 22